CCL3L1-CCR5 genotype improves the assessment of AIDS Risk in HIV-1-infected individuals.

CCL3L1-CCR5 genotype improves the assessment of AIDS Risk in HIV-1-infected individuals.

Whether vexing clinical decision-making dilemmas can be partly addressed by recent advances in genomics is unclear. For example, when to initiate highly active antiretroviral therapy (HAART) during HIV-1 infection remains a clinical dilemma. This decision relies heavily on assessing AIDS risk based...

Full description

Bibliographic Details
Main Authors: Hemant Kulkarni, Brian K Agan, Vincent C Marconi, Robert J O'Connell, Jose F Camargo, Weijing He, Judith Delmar, Kenneth R Phelps, George Crawford, Robert A Clark, Matthew J Dolan, Sunil K Ahuja
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2008-09-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2522281?pdf=render

Internet

http://europepmc.org/articles/PMC2522281?pdf=render

Similar Items